Hexamethonium - Wikipedia
Hexamethonium is a non-depolarising ganglionic blocker, a neuronal nicotinic (nAChR) receptor antagonist [1] that acts in autonomic ganglia by binding mostly in or on the nAChR receptor, and not the acetylcholine binding site itself.
Hexamethonium: Uses, Interactions, Mechanism of Action
2014年5月28日 · Hexamethonium DrugBank Accession Number DB08960 Background. A nicotinic cholinergic antagonist often referred to as the prototypical ganglionic blocker. It is poorly absorbed from the gastrointestinal tract and does not cross the blood-brain barrier.
Hexamethonium - an overview | ScienceDirect Topics
2001年6月2日 · Hexamethonium, a nicotinic acetylcholine receptor antagonist, is often referred to as the prototypical ganglionic blocker. It is a bis-quaternary ammonium compound, having two quaternary nitrogen atoms separated by a bridge of six methylene groups.
Hexamethonium - an overview | ScienceDirect Topics
Hexamethonium is the prototypical ganglionic blocking drug belonging to the bis-quaternary ammonium compounds, having two quaternary nitrogen atoms separated by a bridge of 6 methylene groups. From: xPharm: The Comprehensive Pharmacology Reference, 2009
Hexamethonium - an overview | ScienceDirect Topics
2001年6月2日 · Hexamethonium is a chemical compound that is used as a prototypical ganglionic blocking drug in neuroscience. It is a bis-quaternary ammonium compound, consisting of two quaternary nitrogen atoms separated by a bridge of 6 methylene groups.
Hexamethonium | drug | Britannica
pharmaceutical, substance used in the diagnosis, treatment, or prevention of disease and for restoring, correcting, or modifying organic functions. (See also pharmaceutical industry.) Records of medicinal plants and minerals date to ancient Chinese, Hindu, and Mediterranean civilizations.
Hexamethonium Bromide - DrugBank Online
Hexamethonium A nicotinic cholinergic antagonist often referred to as the prototypical ganglionic blocker. It is poorly absorbed from the gastrointestinal tract and does not cross the blood-brain barrier.
Hexamethonium | C12H30N2+2 | CID 3604 - PubChem
Hexamethonium is a quaternary ammonium salt. A nicotinic cholinergic antagonist often referred to as the prototypical ganglionic blocker. It is poorly absorbed from the gastrointestinal tract and does not cross the blood-brain barrier.
Pharmacology and clinical use of ganglionic blocking agents in the ...
Hexamethonium, pentolinium and mecamylamine are all classified as ganglionic blocking agents. However, mecamylamine appears to be the compound of choice because of longer duration of action, gastrointestinal absorbability and smoothness of effect.
The Treatment of Hypertension with Hexamethonium
2020年5月1日 · Hexamethonium by subcutaneous injection in doses of 10 to 75 mg. of the ion every 8 or 12 hours produced significant reductions of arterial pressure and symptomatic improvement in a high percentage of patients with benign or malignant hypertension.
- 某些结果已被删除